Freedom EVO^® series

VolitionRx is using its proprietary Nucleosomics® technology platform to develop a range of diagnostic assays for cancer and other conditions, creating non-invasive tests that identify disease-specific nucleosome signatures circulating in the blood. High throughput biomarker validation is a crucial aspect of the company’s workflow, which it has chosen to automate using four identical Freedom EVO® 200 workstations.

US-based PhenoLogix is offering a new paradigm in SPE method development for CROs and diagnostic labs. Combining the Freedom EVO® SPE workstation with the Phenomenex Strata™-X 96-Well SPE Method Development Plates, this approach reduces development time from six to seven days to under two hours.

The Molecular Biology Department at Colombia’s Laboratorio Clinico Medico Colcan is using a Freedom EVO® 150 liquid handling platform to automate its nucleic acid extraction and real-time PCR protocols, offering increased flexibility and helping to improve sample throughput.

The Institut Européen de Chimie et Biologie is investigating a variety of innovative aptamer-based applications, and depends on two Freedom EVO® platforms for reliable automation of its selection and production processes

University Hospital Regensburg has taken advantage of the open architecture of the Freedom EVO® workstation, creating a seamless connection between its routine diagnostics and biobanking activities. Working in partnership with the hospital’s Institute for Laboratory Medicine and Transfusion Medicine and diagnostic instruments provider, the Tecan Integration Group has developed a bespoke solution which offers fully automated preparation of samples for both biobanking and offline secondary testing.

With an ever-increasing workload, Germany’s Munich Leukemia Laboratory has automated its cytogenetics protocols on five Freedom EVO® workstations, enabling leaner, standardized, more effi cient processing and minimizing the potential for human error

Extended periods of walkaway operation are essential to the work carried out by Spanish energy producer Repsol, which relies on two Freedom EVO® platforms and Tecan’s 350 µl nested liquid handling disposable tips for its research into alternative energy sources.

Researchers at the Victorian Infectious Diseases Reference Laboratory have completely automated an influenza hemagglutination inhibition assay on a Freedom EVO® workstation using the newly developed FluHema™ module from SciRobotics. It is the first laboratory in the world to achieve this, now running and analyzing up to 128 microplates daily with far better flexibility, reproducibility and overall assay performance.

The Sanford Health BioBank in the USA is using a Freedom EVO® HSM workstation and ReliaPrep™ Large Volume HT gDNA Isolation System for reliable, automated extraction of DNA from blood for genomic medical research.

A Freedom EVO® 150 workstation is providing the Central Diagnostic Laboratory at SAC Consulting with reproducible and reliable ELISA-based screening for Johne’s disease and other bacterial and viral pathogens in cattle. The system has increased the laboratory’s throughput by three-fold compared to manual processing, to an average of 1,000 samples a day.